Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 8/20 | 0.59 |
| ▸ | FLT3 | P36888 | 6/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | PANK3 | Q9H999 | 4/20 | 0.55 |
| ▸ | IGF1R | P08069 | 1/20 | 0.48 |
| ▸ | AURKA | O14965 | 2/20 | 0.47 |
| ▸ | NAMPT | P43490 | 2/20 | 0.47 |
| ▸ | RGS12 | O14924 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.46 |
| ▸ | JAK3 | P52333 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24426177 | 0.88 | JAK2 (0.76) | JAK2FLT3TP53MAPTMAPK1 | |
| SCHEMBL28439476 | 0.88 | FGFR4 (0.49) | JAK2FLT3PANK3SMN1; SMN2 | |
| SCHEMBL28434553 | 0.82 | MAPT (0.65) | JAK2FLT3TP53MAPTMAPK1 | |
| SCHEMBL28439474 | 0.82 | TAAR1 (0.51) | — | |
| SCHEMBL24426219 | 0.82 | FGFR4 (0.64) | JAK2FLT3PANK3JAK3 | |
| SCHEMBL16662319 | 0.80 | JAK2 (0.58) | JAK2FLT3MAPTPANK3NAMPT | |
| SCHEMBL24426217 | 0.77 | JAK2 (0.83) | JAK2FLT3TP53MAPTMAPK1 | |
| SCHEMBL24426221 | 0.75 | JAK2 (0.86) | JAK2FLT3JAK3 | |
| SCHEMBL28445184 | 0.75 | JAK2 (0.58) | JAK2FLT3MAPTSMN1; SMN2 | |
| SCHEMBL24426194 | 0.75 | JAK2 (0.67) | JAK2FLT3JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220259196-A1 | 2-AMINOPYRIMIDINE COMPOUND AND USES THEREOF | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2022-08-18 | — | — | US | claimed |
| EP-3998254-A1 | 2-AMINOPYRIMIDINE COMPOUND AND APPLICATION THEREOF | Shenyang Pharmaceutical University (CN) | 2022-05-18 | — | — | EP | claimed |
| CN-113891881-A | 2-aminopyrimidine compounds and application thereof | 沈阳药科大学 | 2022-01-04 | — | — | CN | claimed |
| US-20220259196-A1 | 2-AMINOPYRIMIDINE COMPOUND AND USES THEREOF | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2022-08-18 | — | — | US | disclosed |
| EP-3998254-A1 | 2-AMINOPYRIMIDINE COMPOUND AND APPLICATION THEREOF | Shenyang Pharmaceutical University (CN) | 2022-05-18 | — | — | EP | disclosed |
| EP-3998254-A1 | 2-AMINOPYRIMIDINE COMPOUND AND APPLICATION THEREOF | Shenyang Pharmaceutical University (CN) | 2022-05-18 | — | — | EP | disclosed |
| CN-113891881-A | 2-aminopyrimidine compounds and application thereof | 沈阳药科大学 | 2022-01-04 | — | — | CN | disclosed |
| CN-111423384-B | 2-aminopyrimidine compounds and application thereof | 沈阳药科大学 | 2021-10-15 | — | — | CN | disclosed |
| WO-2021000884-A1 | 2-AMINOPYRIMIDINE COMPOUND AND APPLICATION THEREOF | 沈阳药科大学 | 2021-01-07 | — | — | WO | disclosed |
| CN-111423384-A | 2-aminopyrimidine compounds and application thereof | 沈阳药科大学 | 2020-07-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259196-A1 | 2-AMINOPYRIMIDINE COMPOUND AND USES THEREOF | DPYD, TPMT, TYMP | JAK2 23/4885FLT3 35/4885TP53 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.